Baxter (BAX) Announces Acquisition of PerClot Polysaccharide Hemostatic System from CryoLife (CRY)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. QQQ
8. LDOS
9. HUM
10. KTOS

Go back to Baxter (BAX) Announces Acquisition of PerClot Polysaccharide Hemostatic System from CryoLife (CRY)

Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio

July 29, 2021 8:00 AM EDT

Marks Baxters entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc (NYSE: CRY) for up to $60.8 million, including $25 million paid upfront. The remainder will be paid out upon achievement of certain select... More